Steroids in Central Retinal Vein Occlusion: Is There a Role in Current Treatment Practice?

Table 2

Comparison between CRUISE and SCORE with regards to visual outcomes.

	CRUISE [9]	SCORE [16]
		Overall	Pseudophakics	Baseline VA (20/80–20/100)
15 letter gains	45.5% (0.3 mg)	26.5% (1 mg)	NS	47% (1 mg)
	46.2% (0.5 mg)	25.6% (4 mg)		38% (4 mg)
Mean change in VA	13.9 gain letters	1-2 letter loss	2 letter gain (1 mg)	7.8 letters gain (1 mg)
	(0.3 mg and 0.5 mg)	(1 mg and 4 mg)	1 letter loss (4 mg)	2.8 letters gain (4 mg)

VA: visual acuity.